Close
  Indian J Med Microbiol
 

Figure 4: Mean changes in (a) total cholesterol, (b) triglyceride, (c) low-density lipoproteins, and (d) high-density lipoproteins from baseline through 60 weeks of treatment.*P < 0.05, the values at baseline versus 4-week (W) visit in a, c, and d; the values at baseline versus 4-, 12-, 24-, and 36-week visits in b. LDL: low-density lipoprotein; HDL: high-density lipoprotein; EPIC-26: the Expanded Prostate Cancer Index Composite-26.

Figure 4: Mean changes in (<b>a</b>) total cholesterol, (<b>b</b>) triglyceride, (<b>c</b>) low-density lipoproteins, and (<b>d</b>) high-density lipoproteins from baseline through 60 weeks of treatment.<sup>*</sup><i>P</i> < 0.05, the values at baseline versus 4-week (W) visit in <b>a</b>, <b>c</b>, and <b>d</b>; the values at baseline versus 4-, 12-, 24-, and 36-week visits in <b>b</b>. LDL: low-density lipoprotein; HDL: high-density lipoprotein; EPIC-26: the Expanded Prostate Cancer Index Composite-26.